(15 days)
Not Found
No
The description focuses on the mechanical and electrical components (RF energy, optical fiber) for visualization and crossing occlusions, with no mention of AI or ML for analysis, decision-making, or image processing.
Yes
The device is used to facilitate the placement of other devices in vascular interventions for total occlusions, which is a therapeutic purpose to address a medical condition.
No
The device is described as a system for facilitating the placement of devices in vascular interventions. It helps in moving a wire through an occlusion and allows the medical practitioner to visualize structures for navigation, which are interventional functions, not diagnostic ones.
No
The device description explicitly lists hardware components such as "0.014" Safe-Cross RF Crossing Wire", "0.035" Safe-Cross RF Crossing Wire", and "Safe-Cross RF System Console".
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic purposes.
- Device Function: The Safe-Cross Radio Frequency Total Occlusion Crossing System is used within the body to facilitate the placement of devices during vascular interventions. It directly interacts with the patient's anatomy (arteries) and uses energy (RF) to assist in navigating through blockages.
- Intended Use: The intended use clearly states it's for "facilitating the placement of devices used in vascular interventions of total occlusions in native iliac and superficial femoral arteries." This is a therapeutic and interventional use, not a diagnostic one based on analyzing specimens outside the body.
The device is an interventional medical device used for treatment and procedure facilitation, not for diagnosing a condition by analyzing samples.
N/A
Intended Use / Indications for Use
The Safe-Cross® Radio Frequency Total Occlusion Crossing System is indicated for use in facilitating the placement of devices used in vascular interventions of total occlusions in native iliac and superficial femoral arteries (SFA) of the lower extremities.
Product codes
DQX
Device Description
The Safe-Cross Radio Frequency Total Occlusion Crossing System consists of the following:
- 0.014" Safe-Cross RF Crossing Wire Straight and Angled Tip (with Torquer) .
- 0.035" Safe-Cross RF Crossing Wire Straight and Angled Tip (with Torquer) .
- Safe-Cross RF System Console .
The modified Safe-Cross RF System is similar to the predicate Safe-Cross System. The proximal end of the Crossing Wire is connected to a Y-Site hub that houses the optic fiber connector and the RF connector. The optical connector is connected to the OCR input on the console to allow the medical practitioner to visualize structures within the vessel for navigation purposes. The RF connector is connected to the RF output on the console. This allows the medical practitioner to provide discrete RF energy to the distal tip to assist in moving the wire tip through the occlusion in the vessel.
The RF Crossing Wire is packaged in a Tyvek® sealed plastic tray. The packaged RF Crossing Wire is provided "STERILE" (ethylene oxide) and non-pyrogenic, and is intended for single use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
native iliac and superficial femoral arteries (SFA) of the lower extremities
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical practitioner
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
In vitro bench testing was conducted to evaluate the performance characteristics of the modified Safe-Cross System. Benchtop performance test results indicate that the components of the Safe-Cross System satisfy safety and performance requirements of the device specifications and do not raise additional safety issues.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
K033708
510(K) SUMMARY
SUBMITTER INFORMATION
| A. | Company Name: | IntraLuminal Therapeutics, Inc. |
|---|---|---|
| B. | Company Address: | 6354 Corte Del Abeto - Suite A |
| Carlsbad, CA 92009 | ||
| C. | Company Phone: | (760) 918-1820 |
| D. | Company Facsimile: | (760) 603-9615 |
| E. | Contact Person: | Pamela Misajon |
| Vice President of Regulatory Affairs and Quality Assurance |
DEVICE IDENTIFICATION
| A. | Device Trade Name: | Safe-Cross® Radio Frequency Total Occlusion
Crossing System |
|----|----------------------|----------------------------------------------------------------|
| C. | Device Common Name: | Catheter Guide Wire |
| D. | Classification Name: | Catheter Guide Wire |
| E. | Device Class: | Class II (per 21 CFR 870.1330) |
IDENTIFICATION OF PREDICATE DEVICE
The predicate device is the Safe-Cross Radio Frequency Total Occlusion Crossing System, manufactured by IntraLuminal Therapeutics and cleared under Premarket Notification 510(k) K031842.
DEVICE DESCRIPTION
The Safe-Cross Radio Frequency Total Occlusion Crossing System consists of the following:
- 0.014" Safe-Cross RF Crossing Wire Straight and Angled Tip (with Torquer) .
- 0.035" Safe-Cross RF Crossing Wire Straight and Angled Tip (with Torquer) .
- Safe-Cross RF System Console .
The modified Safe-Cross RF System is similar to the predicate Safe-Cross System. The proximal end of the Crossing Wire is connected to a Y-Site hub that houses the optic fiber connector and the RF connector. The optical connector is connected to the OCR
1
1033708
input on the console to allow the medical practitioner to visualize structures within the vessel for navigation purposes. The RF connector is connected to the RF output on the console. This allows the medical practitioner to provide discrete RF energy to the distal tip to assist in moving the wire tip through the occlusion in the vessel.
The RF Crossing Wire is packaged in a Tyvek® sealed plastic tray. The packaged RF Crossing Wire is provided "STERILE" (ethylene oxide) and non-pyrogenic, and is intended for single use only.
INTENDED USE
The Safe-Cross® Radio Frequency Total Occlusion Crossing System is indicated for use in facilitating the placement of devices used in vascular interventions of total occlusions in native iliac and superficial femoral arteries (SFA) of the lower extremities.
TECHNOLOGICAL CHARACTERISTICS
The components of the Safe-Cross System are similar in basic materials, design, construction and performance to the predicate device. The RF Generator and OCR Unit have been combined into a single console. The performance of the modified Safe-Cross System has been verified through software testing and bench testing.
PERFORMANCE DATA
In vitro bench testing was conducted to evaluate the performance characteristics of the modified Safe-Cross System. Benchtop performance test results indicate that the components of the Safe-Cross System satisfy safety and performance requirements of the device specifications and do not raise additional safety issues.
CONCLUSIONS DRAWN FROM STUDIES
On the basis of the testing conducted on the modified Safe-Cross System it may be concluded that the device satisfies safety and performance requirements when used in accordance with the Instructions for Use for the indicated patient population. The modified Safe-Cross System is substantially equivalent to the predicate device.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol resembling an abstract human figure with three wavy lines extending from its side.
Public Health Service
DEC 1 1 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Intraluminal Therapeutics, Inc. c/o Ms. Pamela Misajon 6354 Corte Del Abeto, Suite A Carlsbad, CA 92009
Re: K033708
Safe-Cross® Radio Frequency Total Occlusion Crossing System [Peripheral] Regulation Number: 21 CFR 870.1330 Regulation Name: Wire, Guide, Catheter Regulatory Class: Class II (two) Product Code: DQX Dated: November 25, 2003 Received: November 26, 2003
Dear Ms. Misajon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 – Ms. Pamela Misajon
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA's issuance of a substitution of the requirements of the Act
that FDA has made a determination that your device as a love a needes. You must that FDA has made a delefinitiation administered by other Federal agencies. You must
or any Federal statutes and regulations administered by other registration and listing or any Federal statutes and regulations and united to: registration and listing (2)
comply with all the Act's requirements, including, but not limited to set comply with all the Act's requirements, including, occurer and many of the electronics as set
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice the elect CFR Part 807); labeling (21 CFR Fail 601); good manatasan); and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Path 21 CFR 1000-1050 forth in the quality systems (Sections 53) -542 of the Act); 21 CFR 1000-1050.
product radiation control provisions (Sections 531-542 of the Action S product radiation control provisions (bections of the minderse of your Section 5 10(k)
This letter will allow you to begin marketing your and creation of your device to a lev This letter will allow you to begin marketing your active of your device of your device to a legally premarket notification. The FDA Inding of substantial equivaliation of your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
s and the may and 1648 - 11 1648 - the coulstion and readers not the regula If you desire specific advice for your act 1001) 594-4648. Also, please note the regulation entitled, contact the Office of Compliance at (301) 57 - 10 - (21CFR Patt 807.97). You may obtain "Misbranding by relerence to premarkst nothreation der the Act from the Division of Small
other general information on your responsibilities under the Act from www.er/900) 63 other general information on your responsion.com and and the oll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address
(301)445-0577 or at its intrimed in http://www.fdsmamain.html
Sincerely yours,
Ashley B. Beam
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
Kb33708 510(k) Number:
Safe-Cross® Radio Frequency Total Occlusion Crossing System Device Name:
- The Safe-Cross® Radio Frequency Total Occlusion Crossing Indications For Use: System is indicated for use in facilitating the placement of devices used in vascular interventions of total occlusions in native iliac and superficial femoral arteries (SFA) of the lower extremities.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | |
|---|---|
| (Per 21 CFR 801.109) |
OR
| Over-The-Counter Use | |
|---|---|
| -- | ---------------------- |
(Division Sign-off)
Division of Cardiovascular Devices
| 510(K) Number | K033708 |
|---|---|
| --------------- | --------- |